$IBRX
ImmunityBio, Inc.

2019 Q4 Form 10-K Financial Statement

#000156459020012816 Filed on March 25, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q1 2018 Q4
Revenue $9.000K $5.000K $7.000K
YoY Change 28.57% 0.0% -41.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.120M $6.040M $5.250M
YoY Change -21.52% -58.06% -60.79%
% of Gross Profit
Research & Development $12.00M $11.70M $11.88M
YoY Change 1.01% -11.96% 4.03%
% of Gross Profit
Depreciation & Amortization $2.210M $2.395M $2.790M
YoY Change -20.79% 47.57% 77.71%
% of Gross Profit
Operating Expenses $16.12M $18.34M $17.73M
YoY Change -9.06% -35.17% -30.23%
Operating Profit -$16.11M -$18.34M -$17.72M
YoY Change -9.08% -35.18% -30.22%
Interest Expense $310.0K $410.0K $350.0K
YoY Change -11.43% 1142.42% -55.7%
% of Operating Profit
Other Income/Expense, Net $100.0K $47.00K -$100.0K
YoY Change -200.0% -92.67% 66.67%
Pretax Income -$15.70M -$17.92M -$17.47M
YoY Change -10.13% -35.17% -29.16%
Income Tax -$60.00K -$36.00K -$130.0K
% Of Pretax Income
Net Earnings -$15.64M -$17.89M -$17.34M
YoY Change -9.8% -35.01% -29.19%
Net Earnings / Revenue -173788.89% -357700.0% -247714.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$158.8K -$220.2K -$219.0K
COMMON SHARES
Basic Shares Outstanding 79.09M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $111.9M $98.55M $74.15M
YoY Change 50.97% -19.09% -42.14%
Cash & Equivalents $75.80M $22.28M $16.82M
Short-Term Investments $36.14M $76.27M $57.33M
Other Short-Term Assets $24.00K $80.00K $42.00K
YoY Change -42.86% -75.61% -84.73%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $55.76M $113.4M $88.77M
YoY Change -37.19% -10.54% -32.98%
LONG-TERM ASSETS
Property, Plant & Equipment $60.50M $67.92M $76.89M
YoY Change -21.31% -11.56% 0.21%
Goodwill
YoY Change
Intangibles $0.00 $0.00 $565.0K
YoY Change -100.0% -80.01%
Long-Term Investments $10.80M $13.40M $14.20M
YoY Change -23.94% 57.65% 67.06%
Other Assets $4.386M $314.0K $1.527M
YoY Change 187.23% -21.5% 362.73%
Total Long-Term Assets $87.37M $94.83M $93.18M
YoY Change -6.24% -7.93% -21.02%
TOTAL ASSETS
Total Short-Term Assets $55.76M $113.4M $88.77M
Total Long-Term Assets $87.37M $94.83M $93.18M
Total Assets $143.1M $208.3M $182.0M
YoY Change -21.34% -9.37% -27.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.749M $2.804M $2.793M
YoY Change -37.38% -22.11% -52.38%
Accrued Expenses $5.343M $20.24M $21.10M
YoY Change -74.68% 67.29% 87.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $800.0K $100.0K $1.000M
YoY Change -20.0% -66.67% 233.33%
Total Short-Term Liabilities $11.56M $27.70M $27.26M
YoY Change -57.6% 42.79% 30.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $5.900M
YoY Change -100.0% -100.0% 247.06%
Other Long-Term Liabilities $10.90M $12.80M $0.00
YoY Change 58.02% -100.0%
Total Long-Term Liabilities $10.90M $12.80M $0.00
YoY Change 30.61% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.56M $27.70M $27.26M
Total Long-Term Liabilities $10.90M $12.80M $0.00
Total Liabilities $22.44M $40.50M $35.94M
YoY Change -37.56% 37.29% 13.76%
SHAREHOLDERS EQUITY
Retained Earnings -$662.2M -$595.0M
YoY Change 11.3% 19.3%
Common Stock $783.0M $741.3M
YoY Change 5.63% 3.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $120.7M $167.8M $146.0M
YoY Change
Total Liabilities & Shareholders Equity $143.1M $208.3M $182.0M
YoY Change -21.34% -9.36% -27.35%

Cashflow Statement

Concept 2019 Q4 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$15.64M -$17.89M -$17.34M
YoY Change -9.8% -35.01% -29.19%
Depreciation, Depletion And Amortization $2.210M $2.395M $2.790M
YoY Change -20.79% 47.57% 77.71%
Cash From Operating Activities -$14.88M -$13.08M -$14.03M
YoY Change 6.06% -15.69% 2.86%
INVESTING ACTIVITIES
Capital Expenditures -$680.0K $2.104M -$2.040M
YoY Change -66.67% -57.08% -82.17%
Acquisitions
YoY Change
Other Investing Activities $12.84M -$17.36M $17.96M
YoY Change -28.51% -321.99% -42.38%
Cash From Investing Activities $12.17M -$19.46M $15.91M
YoY Change -23.51% -766.4% -19.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K 39.20M -370.0K
YoY Change -83.78% -46211.76% -88.22%
NET CHANGE
Cash From Operating Activities -14.88M -13.08M -14.03M
Cash From Investing Activities 12.17M -19.46M 15.91M
Cash From Financing Activities -60.00K 39.20M -370.0K
Net Change In Cash -2.770M 6.658M 1.510M
YoY Change -283.44% -152.52% -48.81%
FREE CASH FLOW
Cash From Operating Activities -$14.88M -$13.08M -$14.03M
Capital Expenditures -$680.0K $2.104M -$2.040M
Free Cash Flow -$14.20M -$15.18M -$11.99M
YoY Change 18.43% -25.63% 445.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2793000
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
43-1979754
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
3530 John Hopkins Court
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-267000
CY2018Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
723000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
88772000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-594981000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
5701000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76885000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2018Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8500000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
565000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1527000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2739000
CY2018Q4 us-gaap Assets
Assets
181950000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21104000
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1696000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1667000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27260000
CY2018Q4 nk Financing Obligation Noncurrent
FinancingObligationNoncurrent
5945000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181950000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
36144000
CY2019Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
0
CY2019Q4 us-gaap Assets Current
AssetsCurrent
55757000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1497000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60501000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11729000
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
9253000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4386000
CY2019Q4 us-gaap Assets
Assets
143123000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1749000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5343000
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
486000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3981000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11559000
CY2019Q4 nk Financing Obligation Noncurrent
FinancingObligationNoncurrent
0
CY2019Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
0
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-105000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-662191000
CY2019 dei Entity File Number
EntityFileNumber
001-37507
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
CY2019 dei City Area Code
CityAreaCode
858
CY2019 dei Local Phone Number
LocalPhoneNumber
633-0300
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2018Q4 us-gaap Liabilities
Liabilities
35944000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13900000
CY2019Q4 us-gaap Liabilities
Liabilities
22444000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4105000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-65789000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-99120000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10885000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
298000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
741246000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
782965000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
120679000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
146006000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15508000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16821000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
57328000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65886000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-96729000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-97000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-493000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-96226000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.22
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1921000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-503000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-96423000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80583910
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55718000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49785000
CY2019 us-gaap Operating Expenses
OperatingExpenses
67850000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-98389000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18065000
CY2018 us-gaap Operating Expenses
OperatingExpenses
98436000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57121000
CY2017 us-gaap Operating Expenses
OperatingExpenses
99165000
CY2017 us-gaap Investment Income Net
InvestmentIncomeNet
2665000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
236000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1660000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2204000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-96916000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
162000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2627000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
23382000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
36997000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-463000
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1597000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
143123000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
98460404
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
98460404
CY2019 us-gaap Revenues
Revenues
43000
CY2018 us-gaap Revenues
Revenues
47000
CY2017 us-gaap Revenues
Revenues
45000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42044000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42718000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9818000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-156000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
21456000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
57101000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
99552000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79132220
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34983000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7051000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17000000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24051000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8262000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-771000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1313000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79087734
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79087734
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-67807000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
1642000
CY2018 us-gaap Investment Income Net
InvestmentIncomeNet
1857000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
19000
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
114000
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-65000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5566000
CY2019 nk Operating Lease Right Of Use Asset Non Cash Lease Expense
OperatingLeaseRightOfUseAssetNonCashLeaseExpense
2604000
CY2018 nk Operating Lease Right Of Use Asset Non Cash Lease Expense
OperatingLeaseRightOfUseAssetNonCashLeaseExpense
0
CY2017 nk Operating Lease Right Of Use Asset Non Cash Lease Expense
OperatingLeaseRightOfUseAssetNonCashLeaseExpense
0
CY2019 nk Non Cash Interest Income Expense From Operating Activities
NonCashInterestIncomeExpenseFromOperatingActivities
-246000
CY2018 nk Non Cash Interest Income Expense From Operating Activities
NonCashInterestIncomeExpenseFromOperatingActivities
-291000
CY2018 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
433000
CY2017 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
618000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
157000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
94210087
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
293418000
CY2017 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
61000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1154000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1039000
CY2017 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
15227000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
218844000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23382000
CY2018 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
57000
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
123000
CY2018 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
228000
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
114000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2627000
CY2019 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
35151000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4070000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
127000
CY2019 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
501000
CY2019 us-gaap Profit Loss
ProfitLoss
-65789000
CY2018 us-gaap Profit Loss
ProfitLoss
-96226000
CY2017 us-gaap Profit Loss
ProfitLoss
-96423000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9012000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9555000
CY2017 nk Non Cash Interest Income Expense From Operating Activities
NonCashInterestIncomeExpenseFromOperatingActivities
-720000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
869000
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36997000
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
32000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23872000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
19000
CY2018 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-209000
CY2017 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-299000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4063000
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1151000
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-458000
CY2019 nk Increase Decrease In Accounts Payable Current
IncreaseDecreaseInAccountsPayableCurrent
41000
CY2018 nk Increase Decrease In Accounts Payable Current
IncreaseDecreaseInAccountsPayableCurrent
-1100000
CY2017 nk Increase Decrease In Accounts Payable Current
IncreaseDecreaseInAccountsPayableCurrent
150000
CY2019 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-12020000
CY2018 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
12708000
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-64000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-498000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-497000
CY2019 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-4000
CY2018 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
3000
CY2017 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
32000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9276000
CY2019 nk Increase Decrease In Operating Lease Right Of Use Asset Net
IncreaseDecreaseInOperatingLeaseRightOfUseAssetNet
800000
CY2018 nk Increase Decrease In Operating Lease Right Of Use Asset Net
IncreaseDecreaseInOperatingLeaseRightOfUseAssetNet
0
CY2017 nk Increase Decrease In Operating Lease Right Of Use Asset Net
IncreaseDecreaseInOperatingLeaseRightOfUseAssetNet
0
CY2019 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-1093000
CY2018 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-685000
CY2017 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1562000
CY2019 nk Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2276000
CY2018 nk Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0
CY2017 nk Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-508000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1201000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61362000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63381000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48780000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4182000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13102000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34815000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
412000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2019 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2018 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
723000
CY2017 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2019 nk Payments To Acquire Investments In Equity Securities
PaymentsToAcquireInvestmentsInEquitySecurities
3000
CY2018 nk Payments To Acquire Investments In Equity Securities
PaymentsToAcquireInvestmentsInEquitySecurities
0
CY2017 nk Payments To Acquire Investments In Equity Securities
PaymentsToAcquireInvestmentsInEquitySecurities
8500000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
86618000
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
94770000
CY2017 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
111355000
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
112259000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
165284000
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
254222000
CY2019 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
477000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
19932000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
39221000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
57000
CY2017 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1215000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
501000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
197000
CY2018Q4 nk Financing Obligation Current
FinancingObligationCurrent
965000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
1643000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
2317000
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
4225000
CY2019 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
3000
CY2018 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-463000
CY2017 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-1597000
CY2019 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-4000
CY2018 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
3000
CY2017 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
37000
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
228000
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15227000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
127000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
123000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1039000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38593000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
15789000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15687000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
179000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
179000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
179000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
475000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
668000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000
CY2019 nk Noncash Property And Equipment Purchases Acquired Under Capital Lease
NoncashPropertyAndEquipmentPurchasesAcquiredUnderCapitalLease
0
CY2018 nk Noncash Property And Equipment Purchases Acquired Under Capital Lease
NoncashPropertyAndEquipmentPurchasesAcquiredUnderCapitalLease
0
CY2017 nk Noncash Property And Equipment Purchases Acquired Under Capital Lease
NoncashPropertyAndEquipmentPurchasesAcquiredUnderCapitalLease
19448000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
74000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4664000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9500000
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
751000
CY2018 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
CY2017 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
258000
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
123000
CY2017 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-97000
CY2019 us-gaap Stock Issued1
StockIssued1
29000
CY2018 us-gaap Stock Issued1
StockIssued1
94000
CY2017 us-gaap Stock Issued1
StockIssued1
16000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to valuation of equity-based awards, deferred income taxes and related valuation allowances, preclinical and clinical trial accruals, impairment assessments, useful lives of long-lived assets, loss contingencies, and fair value measurements. We base our estimates on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to concentrations of risk consist principally of cash and cash equivalents and marketable debt securities.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash and cash equivalents are held by one major financial institution in the U.S. and one in Korea.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product candidates developed by us will require approvals or clearances from the U.S. Food and Drug Administration, or FDA, or international regulatory agencies prior to commercial sales. There can be no assurance that any of our product candidates will receive any of the required approvals or clearances. If we were to be denied approval or clearance or any such approval or clearance was to be delayed, it would have a material adverse impact on us.</p>
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 nk Cash And Cash Equivalents Original Maturities
CashAndCashEquivalentsOriginalMaturities
P3M
CY2019 nk Maximum Original Maturity Period Of Short Term Marketable Securities
MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities
P12M
CY2019 nk Minimum Original Maturity Period Of Long Term Marketable Securities
MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities
P12M
CY2019 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2018 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2017 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2019 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P4Y
CY2019Q4 nk Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories
FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
0
CY2018Q4 nk Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories
FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
0
CY2017Q4 nk Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories
FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
0
CY2019 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2019 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12 months or less at lease inception
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000
CY2019 nk Variable Consideration Related To Milestone Payment
VariableConsiderationRelatedToMilestonePayment
0
CY2019 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
0
CY2019Q4 nk Number Of Products Approved For Commercial Sale
NumberOfProductsApprovedForCommercialSale
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5646378
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24950411
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24302527
CY2019Q4 nk Prepaid Preclinical And Clinical Trial Services With Related Party
PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty
1021000
CY2018Q4 nk Prepaid Preclinical And Clinical Trial Services With Related Party
PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty
0
CY2019Q4 nk Insurance Premium Financing Asset
InsurancePremiumFinancingAsset
757000
CY2018Q4 nk Insurance Premium Financing Asset
InsurancePremiumFinancingAsset
339000
CY2019Q4 nk Prepaid Supplies With Related Party
PrepaidSuppliesWithRelatedParty
467000
CY2018Q4 nk Prepaid Supplies With Related Party
PrepaidSuppliesWithRelatedParty
532000
CY2019Q4 nk Prepaid Services
PrepaidServices
440000
CY2018Q4 nk Prepaid Services
PrepaidServices
230000
CY2019Q4 us-gaap Prepaid Rent
PrepaidRent
392000
CY2018Q4 us-gaap Prepaid Rent
PrepaidRent
536000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
372000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
343000
CY2019Q4 nk Prepaid Equipment Maintenance
PrepaidEquipmentMaintenance
251000
CY2018Q4 nk Prepaid Equipment Maintenance
PrepaidEquipmentMaintenance
329000
CY2019Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
222000
CY2018Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
473000
CY2019Q4 nk Prepaid License Fees
PrepaidLicenseFees
78000
CY2018Q4 nk Prepaid License Fees
PrepaidLicenseFees
104000
CY2019Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
34000
CY2018Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
10882000
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
47000
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
90000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
24000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
42000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79108000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88446000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18607000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11561000
CY2019 us-gaap Depreciation
Depreciation
8400000
CY2018 us-gaap Depreciation
Depreciation
7300000
CY2017 us-gaap Depreciation
Depreciation
3300000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2300000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2300000
CY2019Q4 nk Prepaid Preclinical And Clinical Trial Services With Related Party In Other Assets
PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets
4075000
CY2018Q4 nk Prepaid Preclinical And Clinical Trial Services With Related Party In Other Assets
PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets
0
CY2019Q4 us-gaap Security Deposit
SecurityDeposit
113000
CY2018Q4 us-gaap Security Deposit
SecurityDeposit
113000
CY2019Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
0
CY2018Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
1205000
CY2019Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
19000
CY2018Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
30000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2002000
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2079000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1064000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
943000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
975000
CY2019Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
0
CY2018Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
3341000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
181000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3206000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
912000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2019Q4 nk Financing Obligation Current
FinancingObligationCurrent
757000
CY2019Q4 nk Accrued Franchise Sales Use And Property Taxes
AccruedFranchiseSalesUseAndPropertyTaxes
200000
CY2019Q4 nk Accrued Laboratory Equipment And Supplies
AccruedLaboratoryEquipmentAndSupplies
640000
CY2018Q4 nk Accrued Laboratory Equipment And Supplies
AccruedLaboratoryEquipmentAndSupplies
678000
CY2018Q4 nk Accrued Franchise Sales Use And Property Taxes
AccruedFranchiseSalesUseAndPropertyTaxes
250000
CY2019Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
18000
CY2018Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
104000
CY2019Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
0
CY2019 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2018 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2017 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2019Q4 nk Accrued Preclinical And Clinical Trial Costs
AccruedPreclinicalAndClinicalTrialCosts
281000
CY2018Q4 nk Accrued Preclinical And Clinical Trial Costs
AccruedPreclinicalAndClinicalTrialCosts
704000
CY2019Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0
CY2018Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
12000000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
598000
CY2017Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8500000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
37642000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
10000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
37641000
CY2019 nk Available For Sale Securities Debt Securities Period
AvailableForSaleSecuritiesDebtSecuritiesPeriod
P3M18D
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
11021000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
4245000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
8000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
32010000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
26000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
29373000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
232000
CY2019 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
4000
CY2018 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
3000
CY2017 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
52000
CY2019 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
8000
CY2018 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2017 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
15000
CY2019 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-4000
CY2018 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
3000
CY2017 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
37000
CY2019 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
12000000
CY2019Q3 us-gaap Legal Fees
LegalFees
500000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13532000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2960000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13407000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
800000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M24D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.09
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.09
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
4400000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4271000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3753000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3671000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2546000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1083000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1729000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17053000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2962000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14091000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2800000
CY2019 nk Operating Lease Payments Related To Options To Extend Lease Terms
OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms
3300000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2700000
CY2018Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
138349
CY2018Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
200000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
6403489
nk Stock Repurchased And Retired Excluding Commission During Period Value
StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
31700000
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
100000
CY2019 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
473586
CY2018 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
138349
CY2017 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3633610
CY2019 nk Stock Repurchased And Retired Excluding Commission During Period Value
StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
500000
CY2018 nk Stock Repurchased And Retired Excluding Commission During Period Value
StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
200000
CY2017 nk Stock Repurchased And Retired Excluding Commission During Period Value
StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
15200000
CY2019Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
18300000
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5646378
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2627000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23382000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36997000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
35200000
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
100000
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
100000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-65286000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-94423000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-94734000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-600000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2306000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2182000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-79000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-21000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-8000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-498000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-497000
CY2019 nk Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
-100000
CY2018 nk Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
-506000
CY2017 nk Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
-497000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
78377000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
61915000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8536000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
79281000
CY2019Q4 nk Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
3884000
CY2018Q4 nk Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
0
CY2019Q4 nk Deferred Tax Assets Deferred Depreciation And Amortization
DeferredTaxAssetsDeferredDepreciationAndAmortization
2042000
CY2018Q4 nk Deferred Tax Assets Deferred Depreciation And Amortization
DeferredTaxAssetsDeferredDepreciationAndAmortization
0
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
898000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
845000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
775000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
795000
CY2019Q4 nk Deferred Tax Assets Leases And Other Accrued Liabilities
DeferredTaxAssetsLeasesAndOtherAccruedLiabilities
453000
CY2018Q4 nk Deferred Tax Assets Leases And Other Accrued Liabilities
DeferredTaxAssetsLeasesAndOtherAccruedLiabilities
2909000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
0
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
308000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
94965000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
146053000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
0
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1000
CY2019Q4 nk Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
3233000
CY2018Q4 nk Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
0
CY2019Q4 nk Deferred Tax Liabilities Deferred Depreciation And Amortization
DeferredTaxLiabilitiesDeferredDepreciationAndAmortization
0
CY2018Q4 nk Deferred Tax Liabilities Deferred Depreciation And Amortization
DeferredTaxLiabilitiesDeferredDepreciationAndAmortization
1279000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3233000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1280000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
91732000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
144773000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
91732000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
144773000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.194
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.062
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.053
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
-0.003
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.048
CY2019 nk Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsAct
0.00
CY2018 nk Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsAct
0.00
CY2017 nk Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsAct
-0.534
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.002
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.006
CY2019 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
-0.825
CY2018 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
-0.001
CY2017 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
-0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
-0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.003
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.008
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.805
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.267
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.087
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
CY2019Q4 nk Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Minimum Amount For Elimination Of Several Business Deductions And Credits Including Deductions For Certain Executive Compensation
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation
1000000
CY2017Q4 nk Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Reduction In Deferred Tax Assets
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateReductionInDeferredTaxAssets
51700000
CY2019 nk Research And Development Cumulative Change In Ownership Percentage
ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage
0.50
CY2019Q2 us-gaap Revenues
Revenues
17000
CY2019 nk Period Of Cumulative Ownership Change
PeriodOfCumulativeOwnershipChange
P3Y
CY2019Q4 nk Derecognized Deferred Tax Assets
DerecognizedDeferredTaxAssets
800000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-53000000
CY2019 us-gaap Income Tax Effects Allocated Directly To Equity Equity Transactions
IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions
200000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6577000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
798000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4608000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11983000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
7000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3680000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15656000
CY2019Q4 nk Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate
14100000
CY2019Q1 us-gaap Revenues
Revenues
5000
CY2019Q3 us-gaap Revenues
Revenues
12000
CY2019Q4 us-gaap Revenues
Revenues
9000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
18340000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
17313000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
16077000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
16120000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18335000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17296000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16065000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-16111000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-17885000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-16682000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-15581000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-15641000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81261302
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
98594355
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
98331695
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
98419166
CY2018Q1 us-gaap Revenues
Revenues
5000
CY2018Q2 us-gaap Revenues
Revenues
4000
CY2018Q3 us-gaap Revenues
Revenues
31000
CY2018Q4 us-gaap Revenues
Revenues
7000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
28289000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
28282000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
24139000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
17726000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28284000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28278000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24108000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-17719000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-27519000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-27732000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-23635000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-17340000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79036614
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79107208
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79204765
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79177962

Files In Submission

Name View Source Status
0001564590-20-012816-index-headers.html Edgar Link pending
0001564590-20-012816-index.html Edgar Link pending
0001564590-20-012816.txt Edgar Link pending
0001564590-20-012816-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g4i5nix4zlkt000001.jpg Edgar Link pending
g4i5nix4zlkt000002.jpg Edgar Link pending
g4i5nix4zlkt000003.jpg Edgar Link pending
g4i5nix4zlkt000004.jpg Edgar Link pending
g4i5nix4zlkt000005.jpg Edgar Link pending
g4i5nix4zlkt000006.jpg Edgar Link pending
g4i5nix4zlkt000007.jpg Edgar Link pending
g4i5nix4zlkt000008.jpg Edgar Link pending
g4i5nix4zlkt000009.jpg Edgar Link pending
g4i5nix4zlkt000010.jpg Edgar Link pending
g4i5nix4zlkt000011.jpg Edgar Link pending
g4i5nix4zlkt000012.jpg Edgar Link pending
g4i5nix4zlkt000013.jpg Edgar Link pending
g4i5nix4zlkt000014.jpg Edgar Link pending
g4i5nix4zlkt000015.jpg Edgar Link pending
g4i5nix4zlkt000016.jpg Edgar Link pending
g4i5nix4zlkt000017.jpg Edgar Link pending
g4i5nix4zlkt000018.jpg Edgar Link pending
g4i5nix4zlkt000019.jpg Edgar Link pending
g4i5nix4zlkt000020.jpg Edgar Link pending
g4i5nix4zlkt000021.jpg Edgar Link pending
g4i5nix4zlkt000022.jpg Edgar Link pending
g4i5nix4zlkt000023.jpg Edgar Link pending
g4i5nix4zlkt000024.jpg Edgar Link pending
g4i5nix4zlkt000025.jpg Edgar Link pending
g4i5nix4zlkt000026.jpg Edgar Link pending
g4i5nix4zlkt000027.jpg Edgar Link pending
g4i5nix4zlkt000028.jpg Edgar Link pending
g4i5nix4zlkt000029.jpg Edgar Link pending
g4i5nix4zlkt000030.jpg Edgar Link pending
g4i5nix4zlkt000031.jpg Edgar Link pending
g4i5nix4zlkt000032.jpg Edgar Link pending
g4i5nix4zlkt000033.jpg Edgar Link pending
g4i5nix4zlkt000034.jpg Edgar Link pending
g4i5nix4zlkt000035.jpg Edgar Link pending
g4i5nix4zlkt000036.jpg Edgar Link pending
g4i5nix4zlkt000037.jpg Edgar Link pending
g4i5nix4zlkt000038.jpg Edgar Link pending
g4i5nix4zlkt000039.jpg Edgar Link pending
g4i5nix4zlkt000040.jpg Edgar Link pending
g4i5nix4zlkt000041.jpg Edgar Link pending
g4i5nix4zlkt000042.jpg Edgar Link pending
g4i5nix4zlkt000043.jpg Edgar Link pending
g4i5nix4zlkt000044.jpg Edgar Link pending
g4i5nix4zlkt000045.jpg Edgar Link pending
g4i5nix4zlkt000046.jpg Edgar Link pending
g4i5nix4zlkt000047.jpg Edgar Link pending
g4i5nix4zlkt000048.jpg Edgar Link pending
g4i5nix4zlkt000049.jpg Edgar Link pending
nk-10k_20191231.htm Edgar Link pending
nk-20191231.xml Edgar Link completed
nk-20191231.xsd Edgar Link pending
nk-20191231_cal.xml Edgar Link unprocessable
nk-20191231_def.xml Edgar Link unprocessable
nk-20191231_lab.xml Edgar Link unprocessable
nk-20191231_pre.xml Edgar Link unprocessable
nk-ex1026_1106.htm Edgar Link pending
nk-ex211_11.htm Edgar Link pending
nk-ex231_6.htm Edgar Link pending
nk-ex311_7.htm Edgar Link pending
nk-ex312_8.htm Edgar Link pending
nk-ex321_10.htm Edgar Link pending
nk-ex322_9.htm Edgar Link pending
nk-ex48_1107.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending